Both in Pharmaceuticals
Rein Therapeutics vs Clene
Over the past year RNTX returned −61.7% and CLNN returned −68.0%; their daily moves had a correlation of 0.22.
RNTX −61.7% CLNN −68.0%Growth of $1, one year, split-adjusted
| Metric | RNTX | CLNN |
|---|---|---|
| Price | $0.6700 | $3.83 |
| Market cap | $57.8M | $54.4M |
| Today | −7.79% | −1.79% |
| 1 month | −21.4% | −4.7% |
| 6 months | −35.0% | −37.6% |
| Year to date | −42.2% | −34.8% |
| 1 year | −56.8% | −58.1% |
| Revenue growth (YoY) | — | +233.3% |
| Gross margin | — | 60.0% |
| Net margin | — | −14915.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 276.3× |
| Net cash | $40.6M | -$9.1M |
| Dividend yield | — | — |
| Volatility (60d) | 95.3% | 81.7% |
| Short % of float | 2.6% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).